ZUVOG (Voglibose (0.2mg))

Zuvog 0.3 Tablet is prescribed for managing type 2 diabetes mellitus. It assists in regulating elevated blood glucose levels occurring after meals, particularly in cases where dietary changes and other medications have failed to achieve adequate control. The intake of Zuvog 0.3 Tablet is recommended just prior to eating, and the prescribing physician will determine the appropriate dosage and frequency tailored to individual needs for effective blood sugar management. It is crucial not to discontinue use abruptly without medical advice, as this may lead to increased blood sugar levels, which can result in severe complications, including kidney impairment and vision loss. This medication should be integrated into a comprehensive treatment plan that encompasses a nutritious diet, consistent physical activity, and weight management as directed by a healthcare professional. Continuous monitoring of blood glucose levels is advised while using this medication. Although Zuvog 0.3 Tablet can cause gastrointestinal discomfort, such as gas or abdominal pain, it does not induce hypoglycemia on its own. However, in conjunction with other antidiabetic agents, particularly insulin or sulfonylureas, it can precipitate low blood sugar episodes that necessitate immediate correction with glucose. It is important to inform your healthcare provider of any pre-existing kidney or liver conditions prior to starting this medication, as well as to discuss any other concurrent medications to ensure a safe treatment regimen. Additionally, it is advisable to limit alcohol consumption while on this treatment due to the potential increased risk of hypoglycemia.